Aquestive Therapeutics, Inc. AQST Finished goods
Finished goods at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryFinishedGoods.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s finished goods.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s finished goods?
- Aquestive Therapeutics, Inc. (AQST) reported finished goods of $1.23M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s finished goods changed year-over-year?
- Aquestive Therapeutics, Inc.'s finished goods decreased by 35.2% year-over-year, from $1.89M to $1.23M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s finished goods?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s finished goods has grown at a 4.1% compound annual growth rate (CAGR), from $544K to $664K.
- What does finished goods mean?
- Completed products ready for sale, valued at the lower of cost or net realizable value.